Bod plotting ‘immediate’ overseas move if CBD sleep trial succeeds by Steve Jones July 19, 2023April 30, 2024 Bod Science will immediately look to commercialise its CBD soft gel capsule in international markets should […]
Bod Science faces nervy wait as final patient completes S3 clinical trial by Steve Jones July 10, 2023April 30, 2024
Bod Science to test drug-delivery tech on psychiatric medication by Steve Jones May 31, 2023April 30, 2024
Hopes rising at Bod Science over commercial prospects for Aqua Phase by Steve Jones May 23, 2023April 30, 2024
Bod medical sales fall as demand continues for high-THC products by Steve Jones May 1, 2023April 30, 2024
Company news: Cann Global; Elixinol; Bod Science; AusCann; IvyMed Clinic; Botanix by Steve Jones and Martin Lane April 5, 2023April 30, 2024
Bod Science submits ethics approval for bioavailability study by Steve Jones March 28, 2023April 30, 2024
Industry braces for change in pursuit of long-term success by Steve Jones March 20, 2023April 30, 2024
Bod CEO ‘confident’ firm will register over-the-counter CBD medicine as insomnia trial progresses by Martin Lane March 13, 2023April 30, 2024
Rise of THC flower hits Bod CBD sales as medical revenues fall 29% by Steve Jones February 27, 2023April 30, 2024
